Asia-Pacific
Deals between five more law firms and President Trump and an antitrust lawsuit against Amgen were also among the top talking points this week
Philips and Vivo have entered into a licensing agreement, putting an end to a five-year-old telecom SEP dispute in India
Ericsson joining Avanci Video as a licensor and the EUIPO's plans for AI use were also among the top talking points this week
Leaders at Malaysian law firm Skrine explain why cost remains a major pain point for Malaysian businesses and how client service can help a firm stand out
Sponsored
Sponsored
-
Sponsored by CCPIT Patent and Trademark Law OfficeJi Liu and Shaohui Yuan of CCPIT Patent and Trademark Law Office explain how China balances intellectual property protection and the prevention of monopolistic behaviour, using two significant cases to demonstrate the key points -
Sponsored by Wanhuida Intellectual PropertyZhigang Zhu, Xiaoyang Yang, and Feng Zheng of Wanhuida Intellectual Property outline the intellectual property-related challenges Chinese enterprises face in pursuing growth through overseas expansion, and explain the steps that can help navigate the complexities
-
Sponsored by Anand and AnandAchuthan Sreekumar of Anand and Anand draws on a recent High Court of Delhi ruling on the unauthorised use of Ratan Tata’s identity to consider how Indian jurisprudence protects well-known personal names
-
Sponsored by Tahota Law FirmCharles Feng, Lian Xue, and Chenxi Cui of Tahota Law Firm draw on the case and several other legal disputes to explore the fractious relationship between games console emulators and manufacturers
-
Sponsored by Liu, Shen & AssociatesJun Qiu of Liu, Shen & Associates analyses two recent CNIPA decisions that provide insights into the application of the good faith principle in patent re-examination and invalidation procedures in China
-
Sponsored by Liu, Shen & AssociatesDongguo Liang of Liu, Shen & Associates says DeepSeek should take swift action to address ‘insufficient planning’ in its intellectual property protection strategy and an ‘underdeveloped’ patent portfolio
